Estera Mikina

S. Artwińskiego Str. 3
Kielce, SK 25734, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases.

A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases.

Journal: Thyroid : official journal of the American Thyroid Association

Published: August 11, 2022

Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?

Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?

Journal: Journal of clinical medicine

Published: May 13, 2021

Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma.

Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma.

Journal: Cancers

Published: December 19, 2020

Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?

Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?

Journal: Cancers

Published: January 19, 2020

Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.

Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.

Journal: Cancers

Published: October 11, 2019

Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.

Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.

Journal: Endocrinology

Published: April 24, 2019

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

Journal: PloS one

Published: April 07, 2018

Response to therapy of papillary thyroid cancer of known BRAF status.

Response to therapy of papillary thyroid cancer of known BRAF status.

Journal: Clinical endocrinology

Published: February 19, 2017

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.

Journal: PloS one

Published: January 06, 2016

Showing 1-9 of 9

Last Updated: 09/26/2026